Financhill
Back

ACADIA Pharmaceuticals Vs. Amylyx Pharmaceuticals Industry Stock Comparison

Sell
30

ACAD
ACADIA Pharmaceuticals

Last Price:
15.25
Seasonality Move:
7.01%
Sell
14

AMLX
Amylyx Pharmaceuticals

Last Price:
1.76
Seasonality Move:
101.62%
Sell
30
ACADIA Pharmaceuticals (ACAD) is a Sell

Is ACADIA Pharmaceuticals a Buy, Sell or Hold?

  • The current ACADIA Pharmaceuticals [ACAD] share price is $15.25. The Score for ACAD is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
Amylyx Pharmaceuticals (AMLX) is a Sell

Is Amylyx Pharmaceuticals a Buy, Sell or Hold?

  • The current Amylyx Pharmaceuticals [AMLX] share price is $1.76. The Score for AMLX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • AMLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ACAD Stock Price Chart

What is ACADIA Pharmaceuticals's stock price today?

  • The ACADIA Pharmaceuticals share price today is $15.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.

AMLX Stock Price Chart

What is Amylyx Pharmaceuticals's stock price today?

  • The Amylyx Pharmaceuticals share price today is $1.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing selling pressure, which indicates risk of future bearish movement.

ACAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.66 Sell
Relative Strength Index (14 RSI): 27.51 Sell
Chaikin Money Flow: -769952 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.31 - 17.57) Sell
Bollinger Bands (100): (17.89 - 28.11) Sell

AMLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 25.39 Sell
Chaikin Money Flow: -1523096 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.79 - 2.27) Sell
Bollinger Bands (100): (3.04 - 16.76) Sell

ACAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.63 Sell
20-day SMA: 16.76 Sell
50-day SMA: 18.43 Sell
200-day SMA: 23.81 Sell
8-day EMA: 16.33 Sell
20-day EMA: 16.88 Sell
50-day EMA: 18.67 Sell
200-day EMA: 22.17 Sell

AMLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.94 Sell
20-day SMA: 1.92 Sell
50-day SMA: 4.09 Sell
200-day SMA: 13.92 Sell
8-day EMA: 1.9 Sell
20-day EMA: 2.17 Sell
50-day EMA: 4.59 Sell
200-day EMA: 12.93 Sell

ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.55 per share.

Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.04 per share, an increase next quarter of $0.18 per share, a decrease this year of $2.79 per share, and an increase next year of $0.45 per share.

ACADIA Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amylyx Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):